Metabolism
Metabolism(代谢)
- PPAR(219)
- 5-alpha Reductase(11)
- 5-Lipoxygenase(11)
- Adenosine Deaminase(10)
- Aminopeptidase(15)
- C14ɑ demethylase(2)
- Carbonic Anhydrase(55)
- CETP(9)
- Cholesterol absorption(1)
- CPT1(2)
- CYP3A/CYP450(22)
- Dehydrogenase(43)
- DHFR(7)
- DGAT(10)
- Dopamine β-hydroxylase(10)
- Enolase(5)
- FAAH(38)
- Factor Xa(61)
- Ferroptosis(198)
- Folate Analogue(2)
- Glucokinase(18)
- HLE(1)
- HMG-CoA Reductase(37)
- HSP(100)
- IDO(46)
- KRAS-PDEδ(3)
- MAO(6)
- Metabolic Enzymes(6)
- Neuronal Metabolism(8)
- Oxidative Phosphorylation(26)
- P450(456)
- PDE(250)
- Phospholipase(130)
- Procollagen C Proteinase(1)
- Saccharometabolism(1)
- SCD(20)
- SGLT(29)
- TPH(4)
- Transferase(26)
- Energy Metabolism
- Inorganic Ions
- ALP(1)
- Carbohydrates(36)
- Uric Acid
- Muscle Metabolism
- MDA
- MPO
- Transaminase(3)
- Glutathione Reductase(1)
- Thioredoxin Reductase
- Catalase(15)
- monooxygenase(1)
- PKM2(1)
- Aldehyde dehydrogenase(1)
- Squalene synthase(1)
- Hydrolase(17)
- ornithine decarboxylase(1)
- Amino acid metabolism(3)
- phosphatases(103)
- Pyruvate kinase(13)
- Others(64)
- MGL(1)
- Galactosidase(2)
- 12-Lipoxygenase(1)
- Fatty Acid Synthase (FASN)(9)
- Dihydroorotate Dehydrogenase(13)
- Bile Acids & Microbiome(131)
- Bone Growth & Remodeling(55)
- Carbohydrate Metabolism(166)
- Cofactors & Vitamins(87)
- Dyslipidemias(109)
- Inborn Errors of Metabolism(100)
- Metabolic Syndrome(22)
- Necroptosis(12)
- Necrosis(19)
- Nutrient Sensing(14)
- Phosphodiesterase(34)
- Reproductive Biology(184)
- Thermogenesis(10)
- Sterol Biosynthesis(42)
- Prolyl Hydroxylation Enzymes(2)
- Biliary System(16)
- Metabolic Disease(5)
- Fat Mass and Obesity-associated Protein (FTO)(5)
- SHIP(1)
- FOXO
- Furin(1)
- Liposome(8)
- MetAP
- PGC-1α
- PI5P4K(1)
- Metabolic Diseases(2)
Metabolism 相关产品(3072)
- GC16203Leucovorin CalciumCAS: 6035-45-6纯度: >98.00%
亚叶酸钙(亚叶酸钙盐五水合物)是一种生物叶酸,通常与甲氨蝶呤 (MTX) 一起作为救援剂给药,以降低 MTX 诱导的毒性。
- GC16212EmpagliflozinCAS: 864070-44-0纯度: >99.50% / >98.00%
Empagliflozin (BI 10773)是一种强效、竞争性、选择性的钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂,对人源SGLT-2的IC 50 值为3.1nM。
- GC16248FinasterideCAS: 98319-26-7纯度: >99.50% / >98.00%
Finasteride是一种选择性II型5α还原酶抑制剂,其IC₅₀值为4.2nM,Finasteride能够降低双氢睾酮(DHT)水平,用于治疗男性型脱发(雄激素性脱发)。
- GC16444RosiglitazoneCAS: 122320-73-4纯度: >99.50% / >98.00%
Rosiglitazone是一种具有口服活性的过氧化物酶体增殖物活化受体γ(PPARγ )选择性激动剂,选择性地激活含有PPARγ配体结合域(LBD)的嵌合体,而不是PPARα和PPARδ,EC 50 为60 nM,K d 为40 nM。
- GC16632CDP 840 hydrochlorideCAS: 162542-90-7
CDP 840 hydrochloride (GR259653X) 是一种有效的、选择性的和口服活性的磷酸二酯酶 IV (PDE IV) 抑制剂。
- GC17107PluriSIn #1 (NSC 14613)CAS: 91396-88-2纯度: >99.50%
A selective inhibitor of stearoyl-CoA desaturase
- GC17203Varespladib (LY315920)CAS: 172732-68-2纯度: >98.50% / >98.00%
Varespladib (LY315920)是一种强效、选择性的group IIA, nonpancreatic secretory PLA2 (sPLA2)抑制剂,IC 50 值为9nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC16133 | DGAT-1 inhibitor | 701232-20-4 | >98.00% | |
A DGAT-1 inhibitor | ||||
| GC16149 | Topiramate | 97240-79-4 | >98.00% | |
Topiramate是一种口服有效的磺胺衍生单糖,具有广谱抗癫痫活性。 | ||||
| GC16203 | Leucovorin Calcium | 6035-45-6 | >98.00% | |
亚叶酸钙(亚叶酸钙盐五水合物)是一种生物叶酸,通常与甲氨蝶呤 (MTX) 一起作为救援剂给药,以降低 MTX 诱导的毒性。 | ||||
| GC16212 | Empagliflozin | 864070-44-0 | >99.50% / >98.00% | |
Empagliflozin (BI 10773)是一种强效、竞争性、选择性的钠-葡萄糖共转运蛋白2(SGLT-2)抑制剂,对人源SGLT-2的IC 50 值为3.1nM。 | ||||
| GC16248 | Finasteride | 98319-26-7 | >99.50% / >98.00% | |
Finasteride是一种选择性II型5α还原酶抑制剂,其IC₅₀值为4.2nM,Finasteride能够降低双氢睾酮(DHT)水平,用于治疗男性型脱发(雄激素性脱发)。 | ||||
| GC16347 | Roflumilast | 162401-32-3 | >99.00% | |
A PDE4 inhibitor | ||||
| GC16361 | Geldanamycin | 30562-34-6 | >99.50% | |
Binds Hsp90 and GRP94, inhibits growth of cancer cells | ||||
| GC16418 | CP-91149 | 186392-40-5 | >99.50% | |
A glycogen phosphorylase inhibitor | ||||
| GC16426 | Zardaverine | 101975-10-4 | >98.50% | |
A dual inhibitor of PDE3 and PDE4 | ||||
| GC16444 | Rosiglitazone | 122320-73-4 | >99.50% / >98.00% | |
Rosiglitazone是一种具有口服活性的过氧化物酶体增殖物活化受体γ(PPARγ )选择性激动剂,选择性地激活含有PPARγ配体结合域(LBD)的嵌合体,而不是PPARα和PPARδ,EC 50 为60 nM,K d 为40 nM。 | ||||
| GC16575 | Alizarin | 72-48-0 | >99.00% | |
A CYP450 inhibitor | ||||
| GC16632 | CDP 840 hydrochloride | 162542-90-7 | - | |
CDP 840 hydrochloride (GR259653X) 是一种有效的、选择性的和口服活性的磷酸二酯酶 IV (PDE IV) 抑制剂。 | ||||
| GC16736 | Etomoxir | 124083-20-1 | >99.50% / >98.00% | |
Etomoxir是肉碱棕榈酰转移酶1a(CPT-1a)的不可逆抑制剂。Etomoxir可通过CPT-1a抑制脂肪酸氧化(FAO)和棕榈酸酯氧化。 | ||||
| GC17074 | Tadalafil | 171596-29-5 | >99.50% | |
Tadalafil是一种有效、可逆且具有选择性的磷酸二酯酶5(PDE5)小分子抑制剂,IC 50 为1.8nM。Tadalafil还能够抑制PDE11(IC 50 为11nM)。 | ||||
| GC17107 | PluriSIn #1 (NSC 14613) | 91396-88-2 | >99.50% | |
A selective inhibitor of stearoyl-CoA desaturase | ||||
| GC17193 | MOG (35-55) | 149635-73-4 | - | |
MOG (35-55)是髓磷脂少突胶质细胞糖蛋白的35-55片段。 | ||||
| GC17203 | Varespladib (LY315920) | 172732-68-2 | >98.50% / >98.00% | |
Varespladib (LY315920)是一种强效、选择性的group IIA, nonpancreatic secretory PLA2 (sPLA2)抑制剂,IC 50 值为9nM。 | ||||
| GC17221 | Olprinone Hydrochloride | 119615-63-3 | >99.50% | |
An inhibitor of PDE3 | ||||
| GC17337 | Ketoconazole | 65277-42-1 | >99.50% | |
A triazole antifungal agent | ||||
| GC17378 | U-104 | 178606-66-1 | >99.50% | |
A carbonic anhydrase inhibitor | ||||
| GC17467 | Gimeracil | 103766-25-2 | >99.50% | |
A DYPD inhibitor | ||||
| GC17520 | Anacetrapib (MK-0859) | 875446-37-0 | >99.50% | |
A CETP inhibitor | ||||
| GC17572 | Finasteride acetate | 222989-99-3 | - | |
An inhibitor of 5α-reductase type II | ||||
| GC17598 | Cilomilast | 153259-65-5 | >99.00% | |
A PDE4 inhibitor | ||||
